Unity Biotechnology, Inc. (NASDAQ: UBX) reported Q1 EPS of ($0.76), $0.59 worse than the analyst estimate of ($0.17).

For earnings history and earnings-related data on Unity Biotechnology, Inc. (UBX) click here.